Your browser doesn't support javascript.
loading
ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC).
Loibl, S; Azim, H A; Bachelot, T; Berveiller, P; Bosch, A; Cardonick, E; Denkert, C; Halaska, M J; Hoeltzenbein, M; Johansson, A L V; Maggen, C; Markert, U R; Peccatori, F; Poortmans, P; Saloustros, E; Saura, C; Schmid, P; Stamatakis, E; van den Heuvel-Eibrink, M; van Gerwen, M; Vandecaveye, V; Pentheroudakis, G; Curigliano, G; Amant, F.
Afiliación
  • Loibl S; GBG c/o GBG Forschungs GmbH, Neu-Isenburg; Centre for Haematology and Oncology Bethanien, Frankfurt am Main, Frankfurt; Goethe University Frankfurt, Frankfurt am Main, Frankfurt, Germany. Electronic address: ibylle.loibl@gbg.de.
  • Azim HA; Breast Cancer Center, School of Medicine, Tecnologico de Monterrey, San Pedro Garza Garcia, Nuevo Leon, Mexico.
  • Bachelot T; Department of medical oncology, Centre Léon Bérard, Lyon, France.
  • Berveiller P; Department of Gynecology and Obstetrics, Poissy-Saint Germain Hospital, Poissy; UMR 1198 - BREED, INRAE, Paris Saclay University, RHuMA, Montigny-Le-Bretonneux, France.
  • Bosch A; Division of Oncology, Department of Clinical Sciences, Lund University, Lund; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.
  • Cardonick E; Cooper Medical School at Rowan University, Camden, USA.
  • Denkert C; Philipps-University Marburg and Marburg University Hospital (UKGM), Marburg, Germany.
  • Halaska MJ; Department of Obstetrics and Gynaecology, Third Faculty of Medicine, Charles University in Prague and Universital Hospital Kralovske Vinohrady, Prague, Czech Republic.
  • Hoeltzenbein M; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy, Berlin, Germany.
  • Johansson ALV; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Cancer Registry of Norway, Oslo, Norway.
  • Maggen C; Department of Obstetrics and Prenatal Medicine, University Hospital Brussels, Brussels, Belgium.
  • Markert UR; Placenta Lab, Department of Obstetrics, Jena University Hospital, Jena, Germany.
  • Peccatori F; Gynecologic Oncology Department, European Institute of Oncology IRCCS, Milan, Italy.
  • Poortmans P; Iridium Netwerk, Antwerp; University of Antwerp, Antwerp, Belgium.
  • Saloustros E; Department of Oncology, University General Hospital of Larissa, Larissa, Greece.
  • Saura C; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Schmid P; Cancer Institute, Queen Mary University London, London, UK.
  • Stamatakis E; Department of Anesthesiology, 'Alexandra' General Hospital, Athens, Greece.
  • van den Heuvel-Eibrink M; Princess Máxima Center for Pediatric Oncology, Utrecht.
  • van Gerwen M; Gynecologic Oncology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam; Department of Child and Adolescent Psychiatry and Psychosocial Care, Amsterdam UMC, University of Amsterdam; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Vandecaveye V; Department of Radiology, University Hospitals Leuven, Leuven, Belgium.
  • Pentheroudakis G; European Society for Medical Oncology (ESMO), Lugano, Switzerland.
  • Curigliano G; Division of Early Drug Development, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Amant F; Gynecologic Oncology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam; Division Gynaecologic Oncology, UZ Leuven, Belgium.
Ann Oncol ; 34(10): 849-866, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37572987

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Risk_factors_studies Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Risk_factors_studies Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido